You can buy or sell Amgen and other stocks, options, ETFs, and crypto commission-free!
Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Thousand Oaks, California
52 Week High
52 Week Low
UPDATE 1-FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug(Adds background, analyst comment) Dec 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson'
Pharmacy benefits manager Abarca inks discount deal for Amgen's EnbrelFILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California in this October 21, 2013. REUTERS/Robert Galbraith/Files (Reuters)
Expected Jan 28, After Hours